Skip to main content
VITL $10.90 -5.95%
VITL logo

VITL · Vital Farms, Inc.

Track VITL — free
$10.90 -0.69 (-5.95%) At close · Aug 14
Market Cap
$494.57M
Shares
42.93M
All earnings calls

Earnings call · FY2026 Q2

Vital Farms, Inc. - Second Quarter 2026 Earnings Conference Call

Vital Farms, Inc. - Second Quarter 2026 Earnings Conference Call

Concluded Aug 6, 2026 Audio replay
Aug 6, 2026 49:38 49 turns
Period
FY2026 Q2
Runtime
49:38
Sources
4 artifacts

Executive readout · one minute

What matters this quarter

Vital Farms reported Q2 net sales down 10.1% with margin compression from industry oversupply, price gaps, and excess breaker costs, but management said it executed its calibration plan: price gaps narrowed (~$2.51 to ~$2.36), farmer contract amendments are live, annualized SG&A reduced ~$6-7M, and Q2 is expected to be the financial trough. The company also entered a new $125M term loan and $60M revolver on August 4, 2026, terminating its prior credit facility and share repurchase program.

Price gap narrowing 33 Supply / oversupply management 24 Capital expenditure / VXR pause 23 Distribution / TDP expansion 23 Industry-wide commodity volatility 16 Capital allocation / share repurchase 8

Management tone

Positive

Net tone +35 · moderate hedging

Grounding quotes
  • “while 2026 presented supply dynamics we did not fully anticipate entering the year, we executed decisively to address them, and the early results give us confidence our operational calibration plan is taking hold.”
  • “we believe the second quarter was our financial trough”
  • “we believe we have clear operational momentum as we enter the second half of 2026”
  • “net sales declined 10.1%”

Forward guidance

2 guided metrics

Management's latest ranges and targets are included below.

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $166.03M -10.1% YoY
Diluted EPS -$0.72 -300% YoY
Gross margin 6.6% -32.3 pp YoY
Net income -$31.07M -286.7% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • Price gaps to branded competitors narrowed from ~$2.51 in Q1 to ~$2.36 in Q2, driving improved velocity and household acquisition.
  • Retail dollar share of the shell egg category gained more than 200 basis points year-over-year in Q2, and shell egg units per store per week per item were up 12.5% since the Q1 call.
  • TDPs expected to expand to 170-175 by Q4 2026, the largest yearly gain since the 2020 IPO.
  • Annualized SG&A run rate reduced by approximately $6-7M through staffing and structural actions.

Risks & pressure points

  • Q2 net sales declined 10.1% year-over-year with margin compression from oversupply, price gaps, and excess breaker costs.
  • Company was forced to send excess eggs to the low-revenue breaker channel during the quarter.
  • Vital Crossroads (VXR) construction will be paused by end of 2026, with ~$80-90M of remaining spend deferred.
  • New credit agreements restrict the company's ability to return capital to shareholders and require maintaining liquidity/coverage covenants.
  • Term loan carries a high 7.50% margin over Term SOFR (1.00% floor), meaningfully increasing interest expense.
  • Share repurchase program terminated as part of the refinancing.

Key moments

Jump directly to management's words in the synchronized transcript.

Forward guidance

From the 8-K filed Aug 6, 2026.

Metric Guided
Net Revenue
Fiscal Year 2026
$775M – $800M
Adjusted EBITDA
Fiscal Year 2026
$0 – $10M

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Eggs and Egg Related Products$160.44M -10.1% YoY
Butter and Butter Related Products$5.59M -11.9% YoY

Capital returned

Buybacks · derived
$15.15M
Shares repurchased
1.13M
Full-screen source Call document